The Role of Surgery in Pleural Mesothelioma
|

The Role of Surgery in Pleural Mesothelioma

Pleural Mesothelioma is a rare and aggressive cancer caused by asbestos exposure. The outlook for this disease is often poor, with a typical survival time of 9 to 20 months after treatment. The overall 5-year survival rate is around 5%. However, new treatments that include surgery are helping improve these numbers. A new article from Cancers explains how surgery helps in diagnosing, staging, and treating pleural mesothelioma. Importance of Surgery in Diagnosis and Staging Surgery is very important for diagnosing and staging pleural mesothelioma accurately. During surgery, doctors can take tissue samples to confirm the disease and identify its type. Correct staging, which means figuring out how far the disease has spread, is crucial for planning the right treatment.  Major…

Breaking Ground in Peritoneal Mesothelioma Treatment
| | |

Breaking Ground in Peritoneal Mesothelioma Treatment

Researchers from Spain are trying to understand just how effective a multi-modal therapy is at treating mesothelioma in the abdomen. The treatment is called cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Or, CRS-HIPEC for short. Mesothelioma that is found in the abdomen is called peritoneal mesothelioma. It is caused by the ingestion of asbestos fibers. Those tiny asbestos fibers become stuck in the abdomen. After 20 to 50 years, these fibers can cause inflammation and mutations in the healthy cells in the abdomen. These mutations can cause these cells to form tumors in the abdomen. Patients diagnosed with MPM have longer life expectancy than those with other types of mesothelioma. Some studies report patients live up to 5 years after treatment….